Pomegranate juice is rich in iron and antioxidants, which help boost red blood cells. It is rich in polyphenols, which improve platelet count. This information is taken from the National ...

More airstrikes targeted the Ras Isa oil port held by Yemen's Houthi rebels. Anees al-Asbahi, a spokesman for the Houthi-run health ministry, said in a post on X early Friday that the death toll ...

The United States conducted airstrikes on Yemen’s Ras Isa oil port, which the Houthis control, to disrupt their primary source of revenue and support from Iran. The strikes reportedly caused many ...

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them. (HealthDay News) — Both glucagon-like peptide-1 receptor agonists ...

This study found that using GLP-1 RAs and SGLT2is for type 2 diabetes treatment offers potential neuroprotections against Alzheimer disease and related dementias. HealthDay News — Both glucagon ...

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them ...

According to Houthi–affiliated media, four American air raids struck the Ras Isa fuel port in Hodeida, a critical lifeline for over 25 million Yemenis living in Houthi-controlled areas.

This fuel should be legitimately supplied to the people of Yemen. Despite the Foreign Terrorist Designation that went into effect on 05 April, ships have continued to supply fuel via the port of Ras ...

A big treechange from the sands of Cronulla to the riverbanks of Gresford has been just the start of the journey for the 2025 RAS Rural Achiever.

Egypt and France signed a cooperation agreement to develop, finance, construct, and operate an integrated green hydrogen and ammonia production facility in Ras Shukheir, as per a statement. The ...

Rove Al Marjan Island is located on the stunning beachfront of Al Marjan Island in Ras Al Khaimah. It offers seamless access to the Emirate’s many attractions and five international airports.

SAN DIEGO, CA, USA & BERLIN, Germany I April 03, 2025 I Vividion Therapeutics, Inc. (Vividion) today announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, ...